Efficacy and safety of tofacitinib in the treatment of refractory chronic spontaneous urticaria: A real-world study
Journal of the American Academy of Dermatology · 2026-09
DOI: 10.1016/j.jaad.2026.08.112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Anqi Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, China; Chongqing Municipal Healt…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, China; Chongqing Municipal Health Commission Key Laboratory of Immunological Skin Diseases, Chongqing,…
Zitieren
APA
Chen, A., Li, R., Yang, X., Huang, X., Mu, Z., Li, S., Deng, S., Huan, W., Zhang, M., Li, J., Song, Z., & Chen, Q. (2026). Efficacy and safety of tofacitinib in the treatment of refractory chronic spontaneous urticaria: A real-world study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.08.112
Vancouver
Chen A, Li R, Yang X, Huang X, Mu Z, Li S, et al. Efficacy and safety of tofacitinib in the treatment of refractory chronic spontaneous urticaria: A real-world study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.08.112
BibTeX
@article{Chen2026,
author = {Chen, Anqi and Li, Ruiguo and Yang, Xianjie and Huang, Xuewei and Mu, Zhikun and Li, Shifei and Deng, Sisi and Huan, Wang and Zhang, Mingwang and Li, Jian and Song, Zhiqiang and Chen, Qiquan},
title = {Efficacy and safety of tofacitinib in the treatment of refractory chronic spontaneous urticaria: A real-world study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.08.112}
}
EUVIMED